But it is very important to discuss any dose changes with a healthcare provider beforehand
Currently, warnings on carcinogenic risk have been removed from the drug information of tacrolimus ointments, although the combination with phototherapy is still mentioned with caution
Therefore, to address these potential problems, a longitudinal observation study is required to clarify whether there are clinical differences in oxidative stress and glucose variability between patients with T2DM receiving injectable semaglutide and dulaglutide therapies
Seek immediate medical attention if you experience severe persistent abdominal pain (especially if radiating to your back), persistent vomiting, inability to keep fluids down, dark urine, dizziness, fainting, fever, or yellowing of the skin or eyes